The clinical information you need, at your fingertips.

In a matched real-world cohort of more than 20,000 patients, tirzepatide produced greater average weight loss as well as fewer GI, headache, and fatigue events than semaglutide. . .

A related survey of psychologists reports patients using chatbots for support and self-diagnosis. A slim majority are comfortable with it, but nearly all have concerns. . .

Active-hormone weeks tracked higher emotional eating, with no parallel change in weight preoccupation. . .

Large US cohort found widespread prenatal exposure to phthalates, plasticizer alternatives, and combustion-related pollutants. . .

A 1,000-slot federal residency expansion built to favor specialties with shortages and rural areas didn’t work as intended. . .